# Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma

> **NCT04063189** · PHASE2 · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Myeloma in Relapse

## Interventions

- **DRUG:** Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen

## Key facts

- **NCT ID:** NCT04063189
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-21
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063189, "Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04063189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*